ThermoGenesis names Engle CEO - Sacramento Business Journal:

plesciamipukoa1855.blogspot.com
Matthew Plavan, who has served as the RanchioCordova company’s (Nasdaq: KOOL) interim CEO since December, has becomed the chief operating officer. He will retai n his titles of executive vice president and chieff financial officer ofthe company, whicj makes devices for storing and processing stem cells and bloo d products. “Mel has served as president and CEO of threse healthcare companies, as well as havint extensive management experience in operations, finance, sales and international market developmeny with both large and smalll device and pharmaceutical organizations,” said Patricok McEnany, director and chairman of the company’s governance and nominating committee, in a news “After conducting an extensive search and interviewing a numbetr of excellent candidates, it was clear to the boarcd that Mel’s wide-ranging health care industry experience m ade him a grea t fit for ThermoGenesis.
” Engle’s last job was CEO of , a laser technology company. Before that he spent six yearsz as president and CEOof , a $600 millionn specialty pharmaceutical company affiliated with Merck KGaA. Prior to that he was chairman, president and CEO of , a publicly traded medical device Engle’s has also worked as regionap director in North America for and held senior management positions with He is a member of the boare of directorsof (OTCBB: OXBO), formerly known as , which is developingt oxygen-delivery therapies.
He has a bachelor’xs degree in accounting from the Universit of Colorado anda master’s degree in business administrationb with a specialty in finance from the Universit of Southern California. “I am excited to be joining ThermoGenesis, particularly at a time of heightened interest in and growinbg awareness of the therapeutic value ofstem cells, Englde said in the news release. “ThermoGenesis possesses a strong technology base with a dedicated and knowledgeabler groupof employees. It is well positioned to capitalized on the growing stemcell market.
ThermoGenesis has a trackj record of product innovatiojn and is on the cusp of realizing an increaseds market presence with its current andnew “I appreciate the support of our boarc and employees over the past several monthx and look forward to working with Mel on a furthee implementation of our turnaround Plavan said in the news release.